Page 2 - Merith Basey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merith Basey, executive director of Patients For Affordable Drugs, believes the Medicare price negotiation program is here to stay, no matter who is president and no matter how many Big Pharma players file lawsuits. Her reasoning? Every other high income nation has been negotiating prices with drugmakers for years, and the program is widely popular in the U.S. among pretty much everyone who isn’t a pharma company, she said during a session at Engage at HLTH.

The opening day of the HLTH 2023 event offered a surprising announcement from venture capital firm General Catalyst. Weight Watchers CEO called for a change in how we talk about obesity. ENGAGE at HLTH offered compelling discussions around retail health, prescription drug prices and investment trends.

A high-profile case in in Amarillo, Texas could wipe out access to the abortion pill mifepristone nationwide, Alice reports.

Novo Nordisk, Sanofi face pressure to cut insulin prices following Eli Lilly’s move. From PR Week

After several rounds of treatment for a rare eye cancer—weekly drug infusions that could cost nearly $50,000 each—Paul ...